Griseofulvin Suspension
Product Images NDC 0472-0013

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Griseofulvin (NDC 0472-0013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of the active ingredient Griseofulvin, showing its characteristic substituted benzofuranone ring with methoxy and chloro groups attached.*

FDA Label Image

Image 2

Label for Griseofulvin Oral Suspension USP (microsize) 125 mg/5 mL, an oral suspension by Actavis Pharma, Inc. The label shows the product name, strength, dosage form, quantity of 4 fl oz (120 mL), and directions to shake before using. It includes packaging and dosage information, barcodes, and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.